Dr. Russell Szmulewitz, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Prostate Cancer
Studies Stomach Cancer
16 reported clinical trials
51 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
PSA positive
synaptophysin positive
2Stomach Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Russell Szmulewitz, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Darolutamide vs Enzalutamide
for Prostate Cancer
This is a prospective, randomized, open-label phase II study comparing cognitive outcomes between men with metastatic and non-metastatic castration resistant prostate cancer (CRPC) or metastatic hormone sensitive prostate cancer (HSPC). Approximately 132 patients will be enrolled. Eligible patients will be randomized in a 1:1 fashion to treatment with enzalutamide 160 mg orally daily or darolutamide 600 mg orally twice daily, in combination with standard LHRH agonist based treatment. Cognitive assessments will be performed using modules from Cambridge Neuropsychological Test Automated Battery (CANTAB) an internationally recognized software for assessing cognitive function and impairment.
Recruiting1 award Phase 2
More about Russell Szmulewitz, MD
Clinical Trial Related6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Russell Szmulewitz, MD has experience with
- Enzalutamide
- Darolutamide
- Prednisone
- Abiraterone Acetate
- Apalutamide
- Radical Prostatectomy
Breakdown of trials Russell Szmulewitz, MD has run
Prostate Cancer
Stomach Cancer
Head and Neck Cancers
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Russell Szmulewitz, MD specialize in?
Russell Szmulewitz, MD focuses on Prostate Cancer and Stomach Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PSA positive.
Is Russell Szmulewitz, MD currently recruiting for clinical trials?
Yes, Russell Szmulewitz, MD is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Russell Szmulewitz, MD has studied deeply?
Yes, Russell Szmulewitz, MD has studied treatments such as Enzalutamide, Darolutamide, Prednisone.
What is the best way to schedule an appointment with Russell Szmulewitz, MD?
Apply for one of the trials that Russell Szmulewitz, MD is conducting.
What is the office address of Russell Szmulewitz, MD?
The office of Russell Szmulewitz, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60453 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.